GSK

Latest news

1. 14 Oct
   Cerebras CEO criticises AI doomsday narrative at TechCrunch Disrupt 2026

   Andrew Feldman, CEO and co‑founder of AI chipmaker Cerebras Systems, said the AI doomer narrative is unhelpful and that leaders should emphasise AI's benefits as well as risks. Feldman spoke at TechCrunch Disrupt 2026 and noted his company works with major AI customers while acknowledging trade‑offs between risk and reward.

   Policy · 1 source

   

Articles

No articles about GSK yet.